Ryo Kitagawa

Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505

Ryo Kitagawa, Noriyuki Katsumata, Taro Shibata et al. · Journal of Clinical Oncology · 2015 · 382 citations · Full text

Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: Efficacy and toxicity of a low cumulative radiation dose schedule

Takafumi Toita, Ryo Kitagawa, Tetsutaro Hamano et al. · Gynecologic Oncology · 2012 · 110 citations

Concurrent Chemoradiotherapy, High-dose-rate Intracavitary Brachytherapy, Cervical Cancer +8

Neuronal specificity of α-synuclein toxicity and effect of Parkin co-expression in primates

Toru Yasuda, S. Miyachi, Ryo Kitagawa et al. · Neuroscience · 2006 · 72 citations

Parkin Co-expression, Neurodegenerative Diseases, Molecular Neuroscience +14

Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition

Satoru Nagase, Yoshiki Inoue, Naohiko Umesaki et al. · International Journal of Clinical Oncology · 2010 · 58 citations

Cervical Cancer Screening, Cervical Cancer Management, Cervical Cancer +12

A Phase III Trial of Paclitaxel plus Carboplatin Versus Paclitaxel plus Cisplatin in Stage IVB, Persistent or Recurrent Cervical Cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)

I. Saito, Ryo Kitagawa, Hiroshi Fukuda et al. · Japanese Journal of Clinical Oncology · 2009 · 56 citations · Full text

Gynecology, Cancer Registration, Surgery +17